Brawn Biotech Reports Q2 Results with Net Profit Falling to Rs 3.03 Lacs
Brawn Biotech Ltd 路 Financial Result 路 05 Nov 2026, 8:08 pm
Brawn Biotech Reports Q2 Results with Net Profit Falling to Rs 3.03 Lacs Brawn Biotech reported standalone revenue from operations of Rs 562.45 lacs for the quarter ended 30th Sep'26, rising 14.99% YoY from Rs 489.10 lacs but declining 7.47% QoQ from Rs 607.88 lacs. Net profit dropped 57.56% YoY to Rs 3.03 lacs compared to Rs 7.14 lacs on 30th Sep'25 and Rs 15.44 lacs on 30th Jun'26. Basic and diluted EPS fell to Rs 0.12 from Rs 0.25 YoY. For the half-year ended 30th Sep'26, revenue reached Rs 1,170.33 lacs with net profit at Rs 18.46 lacs.
Original exchange filing (PDF)
More announcements from Brawn Biotech Ltd
- Intimation regarding non-applicability of regulation 23(9) 路 05 Nov 2026
- Outcome Of Board Meeting Held On 5th November, 2026 To Consider And Approve, Inter-Alia, Un-Audited Financial Results Of The Company For Quarter Ended September 30, 2026. 路 05 Nov 2026
- Brawn Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Un-Audited Financial Results .... 路 05 Nov 2026
- Disclosure under Regulation 30 of SEBI LODR Regulations, 2015 路 29 Sept 2026
- Scrutinizers Report attached along with voting results for 41st AGM 路 29 Sept 2026
- Proceedings of 41st AGM 路 29 Sept 2026
- Outcome of 41st Annual General Meeting 路 29 Sept 2026
- Letters sent to shareholders as per Reg 36 路 02 Sept 2026
